Koh, J., Kim, Y., Lee, K. Y., Hur, J. Y., Kim, M. S., Kim, B., . . . Ahn, M. (2020). MDSC subtypes and CD39 expression on CD8(+) T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC. Eur J Immunol.
Chicago Style CitationKoh, Jiae, et al. "MDSC Subtypes and CD39 Expression On CD8(+) T Cells Predict the Efficacy of Anti‐PD‐1 Immunotherapy in Patients With Advanced NSCLC." Eur J Immunol 2020.
Cita MLAKoh, Jiae, et al. "MDSC Subtypes and CD39 Expression On CD8(+) T Cells Predict the Efficacy of Anti‐PD‐1 Immunotherapy in Patients With Advanced NSCLC." Eur J Immunol 2020.
Atenció: Aquestes cites poden no estar 100% correctes.